Editorial: Reviews in hematologic malignancies

por Saraceni, Francesco, Morè, Sonia
Publicado 2022

Novel Experimental Drugs for Treatment of Multiple Myeloma

por Offidani, Massimo, Corvatta, Laura, Morè, Sonia, Olivieri, Attilio
Publicado 2021

Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and Safety

por Offidani, Massimo, Corvatta, Laura, Morè, Sonia, Olivieri, Attilio
Publicado 2021

Current Main Topics in Multiple Myeloma

por Morè, Sonia, Corvatta, Laura, Manieri, Valentina Maria, Olivieri, Attilio, Offidani, Massimo
Publicado 2023

Belantamab Mafodotin: From Clinical Trials Data to Real-Life Experiences

por Morè, Sonia, Offidani, Massimo, Corvatta, Laura, Petrucci, Maria Teresa, Fazio, Francesca
Publicado 2023

P912: ADDING REFRACTORINESS STATUS TO LINES OF THERAPY BETTER DEFINE PROGNOSIS OF A REAL LIFE ITALIAN MULTIPLE MYELOMA POPULATION

por More’, Sonia, Corvatta, Laura, Maria Manieri, Valentina, Morsia, Erika, Olivieri, Attilio, Offidani, Massimo
Publicado 2023

P973: ATTRITION PROBABILITY AND PREDICTORS AMONG MULTIPLE MYELOMA PATIENTS TREATED IN AN ITALIAN HAEMATOLOGICAL TERTIARY CARE CENTRE

por More’, Sonia, Corvatta, Laura, Maria Manieri, Valentina, Morsia, Erika, Olivieri, Attilio, Offidani, Massimo
Publicado 2023

Novel Immunotherapies and Combinations: The Future Landscape of Multiple Myeloma Treatment

por Morè, Sonia, Corvatta, Laura, Manieri, Valentina Maria, Morsia, Erika, Poloni, Antonella, Offidani, Massimo
Publicado 2023

Monoclonal Antibodies: Leading Actors in the Relapsed/Refractory Multiple Myeloma Treatment

por Morè, Sonia, Petrucci, Maria Teresa, Corvatta, Laura, Fazio, Francesca, Offidani, Massimo, Olivieri, Attilio
Publicado 2020

Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments

por Offidani, Massimo, Corvatta, Laura, Morè, Sonia, Nappi, Davide, Martinelli, Giovanni, Olivieri, Attilio, Cerchione, Claudio
Publicado 2021

Autologous Stem Cell Transplantation in Multiple Myeloma: Where Are We and Where Do We Want to Go?

por Morè, Sonia, Corvatta, Laura, Manieri, Valentina Maria, Saraceni, Francesco, Scortechini, Ilaria, Mancini, Giorgia, Fiorentini, Alessandro, Olivieri, Attilio, Offidani, Massimo
Publicado 2022

PB2189: UNUSUAL SITE THROMBOSIS IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS: THE EXPERIENCE WITH 66 CONSECUTIVE CASES.

por Morsia, Erika, Ranalli, Paola, Torre, Elena, More’, Sonia, Stefano, Baldoni, Mancini, Stefania, Battilà, Ilaria, Martini, Francesco, Tarantino, Giuseppe, Baroni, Gianluca Svegliati, Olivieri, Attilio, Rupoli, Serena, Ianni, Mauro DI
Publicado 2023

Response to BNT162b2 Sars-Cov-2 Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant

por Saraceni, Francesco, Fiorentini, Alessandro, Morè, Sonia, Guerzoni, Selene, Puglisi, Bruna, Corvaro, Benedetta, Caucci, Sara, Menzo, Stefano, Costantini, Andrea, Butini, Luca, Viola, Nadia, Scortechini, Ilaria, Mancini, Giorgia, Dubbini, Maria Vittoria, Federici, Irene, Kordasti, Shahram, Offidani, Massimo, Patriarca, Francesca, Battista, Marta Lisa, Chiarucci, Martina, Visani, Giuseppe, Falcioni, Sadia, Galieni, Piero, Natale, Annalisa, Vaddinelli, Doriana, Santarone, Stella, Colasante, Fabrizia, Carella, Angelo Michele, Battipaglia, Giorgia, Pane, Fabrizio, Olivieri, Attilio
Publicado 2021